Recent Finacing
Recent Raise
ROSLINCT is a UK-based contract manufacturing organization serving cell and gene therapy, combining automation and GMP manufacturing to develop RNA-based reprogramming workflows for clinical-grade iPSC production, scale-up, and licensing.
